Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sensome (formerly Instent) is a French medical technology company that has developed a breakthrough sensor technology for the real-time characterization of biological tissues. The company's proprietary platform integrates ultra-miniaturized impedance sensors and machine learning algorithms into minimally invasive medical devices, such as guidewires and stents. Its lead product, the ClotScan smart guidewire, allows interventional neuroradiologists to identify the composition of a blood clot during a stroke intervention, enabling more informed treatment decisions and improving patient outcomes. Originally founded to develop "smart stents" for monitoring arterial healing, the company has since expanded its focus to neurovascular and peripheral vascular applications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Instent.